REGN-844

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameREGN-844
Drug Alias Nameanti-IL-6 receptor murine antibody (Regeneron Pharmaceuticals)REGN-844
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionInterleukin-6 receptor alpha subunit antagonists
TargetsInterleukin-6 receptor alpha subunit
Therapy Area/IndicationsUveitisXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRegeneron Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRegeneron Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsUveitisXerophthalmia

Other Information

ATC CodeN/A
Related LinksN/A